Key facts
- Raaz’s last known valuation is $3.5M (Jan 2025).
- It has raised $890K; the latest was Seed Round ($890K) in Jan 2025.
- Notable investors include Fireside Ventures, Campus Fund (India), Altaf Saiyed, Bhargav Tarpara, Raymond Russell — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Raaz
- ·The full record, as it builds
Funding rounds
No funding rounds for Raaz are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Raaz
Operator of men's reproductive healthcare platform intended to provide treatment for venereal disease. The company platform offers a native language application interface, evidence-based treatment programs, consultancy services, and medications, enabling patients to take control of their health and personalized care.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2023
- Employees
- 21
- Website
- raaz.app/
- Ownership
- Privately Held (backing)
Raaz doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Raaz shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Raaz in its N-PORT filings yet. We sweep new filings monthly.